Bard Avaulta TVM Legal News Articles & Interviews

Santa Clara, CA: Manufacturers of transvaginal mesh have been issued with final orders from the US Food and Drug Administration (FDA) that strengthen the data requirements for surgical mesh to repair pelvic organ prolapse (POP) transvaginally, or through the vagina. Hundreds of lawsuits have been filed against the manufacturers of these devices alleging mesh erosion, infection, pelvic pain and urinary problems.

Port Washington, New York (August 11, 2014) C.R. Bard indicated the settlement in its second-quarter filing with the U.S. Securities and Exchange Commission (SEC).

Charleston, WV The Avaulta mesh lawsuit that recently ended in a ruling favoring the plaintiff could set the tone for similar lawsuits regarding the Bard Avaulta mesh implant and other implants designed to treat Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI). One of the points argued by plaintiff lawyers at the trial was that officials with C.R. Bard Inc. allegedly knew that the plastic used to manufacture the Avaulta mesh carried, it was alleged, a warning that the material should not be permanently implanted in humans.

Atlanta, GA A jury hearing the first transvaginal mesh personal injury lawsuit has awarded the plaintiff $2 million in damages. In her lawsuit, Donna Cisson alleges that the mesh, one of the line of Avaulta transvaginal mesh products made by C.R. Bard Inc, which she had surgically implanted, caused her bleeding and pain. The Avaulta transvaginal mesh was implanted to treat pelvic organ prolapse (POP), a condition which can cause urinary incontinence and pain, including during sex. Cisson subsequently underwent two surgeries to have the medical device removed.

Richmond, WV A lawsuit filed against CR Bard Inc, concerning the company’s Avaulta mesh product, alleges that the company knew that the transvaginal Avaulta mesh implant was not fit for use in humans, but sold the product anyhow. The lawsuit, which resulted in a mistrial, is set to go before the court again at the end of July, and alleges patients were harmed by the use of the Bard Avaulta mesh.

Boston, MA A new study suggests that there is a risk of side effects associated with the use of Avaulta mesh and other transvaginal mesh products. The study appears to confirm previous concerns that transvaginal mesh products such as the Avaulta mesh implant are associated with a risk of mesh erosion.

Philadelphia, PA Women who have had an Avaulta mesh implant say they have been harmed by the mesh, which is alleged to have been defectively designed. The Avaulta lawsuits are not the first involving transvaginal mesh products, some of which reportedly caused serious health problems for women. Bellwether trials involving the Avaulta mesh implant are expected to be heard in court in the next few months.

Jacksonville, FL Carol has been suffering complications from Bard’s Avaulta transvaginal mesh since 2005, during which four months of that time she wound up in the Mayo Clinic. She is hopeful that surgery tomorrow will remove the Avaulta mesh, allow her body to heal and pull her out of this “downward spiral.”

Atlantic City, NJ A recent jury award totaling $11.1 million for a transvaginal mesh plaintiff serves as hope for the hundreds of other plaintiffs pursuing an Avaulta lawsuit, together with those chasing more than 30 other manufacturers of the allegedly faulty product.

Charleston, WV The first transvaginal mesh trial against C.R. Bard and its Avaulta Transvaginal Mesh product was set for February 5, 2013. The push is on to get Bard’s device and other vaginal mesh products off the market before they can do further harm.